Immediate Impact
24 from Science/Nature 73 standout
Citing Papers
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
Biomedicine Meets Fenton Chemistry
2021 Standout
Works of Matthieu Monge being referenced
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
2015 Standout
Analysis of transcriptomic and proteomic profiles demonstrates improved Madin–Darby canine kidney cell function in a renal microfluidic biochip
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Matthieu Monge | 410 | 123 | 367 | 253 | 34 | 1.4k | |
| James D. McFadyen | 379 | 221 | 358 | 77 | 66 | 1.7k | |
| Francesco Bagaglia | 522 | 123 | 330 | 201 | 40 | 1.5k | |
| Mohammad Ali | 425 | 81 | 332 | 328 | 23 | 1.1k | |
| Alberto Benito‐Martín | 912 | 124 | 142 | 373 | 40 | 1.7k | |
| Koichi Sohmiya | 485 | 137 | 498 | 123 | 65 | 1.3k | |
| Jidong Su | 594 | 76 | 309 | 75 | 23 | 1.4k | |
| Patrizia Della Valle | 355 | 209 | 270 | 62 | 45 | 1.5k | |
| Bin Wang | 844 | 116 | 53 | 296 | 38 | 1.5k | |
| Andrew Salmon | 419 | 211 | 180 | 106 | 34 | 1.7k | |
| Eric D. Morrell | 269 | 231 | 117 | 67 | 51 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...